tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market

Glenmark Pharmaceuticals Limited (GLENMARK) Ratios

Compare
4 Followers

Glenmark Pharmaceuticals Limited Ratios

IN:GLENMARK's free cash flow for Q1 2026 was ₹0.69. For the 2026 fiscal year, IN:GLENMARK's free cash flow was decreased by ₹ and operating cash flow was ₹0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.00 1.28 1.28 1.96 1.77
Quick Ratio
0.00 0.84 0.84 1.37 1.23
Cash Ratio
0.00 0.28 0.28 0.29 0.30
Solvency Ratio
-0.13 -0.14 -0.14 0.10 0.19
Operating Cash Flow Ratio
0.00 -0.05 -0.05 0.12 0.24
Short-Term Operating Cash Flow Coverage
0.00 -0.27 -0.27 1.26 1.01
Net Current Asset Value
₹ 88.49B₹ 9.17B₹ 9.17B₹ 3.41B₹ 6.37B
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.09 0.09 0.24 0.23
Debt-to-Equity Ratio
0.00 0.16 0.16 0.49 0.44
Debt-to-Capital Ratio
0.00 0.14 0.14 0.33 0.30
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.29 0.22
Financial Leverage Ratio
0.00 1.83 1.83 2.04 1.88
Debt Service Coverage Ratio
8.59 -0.49 -0.49 0.79 1.27
Interest Coverage Ratio
13.91 1.22 1.22 4.77 6.17
Debt to Market Cap
0.00 0.04 0.04 0.33 0.29
Interest Debt Per Share
7.99 61.91 61.91 176.38 150.98
Net Debt to EBITDA
0.00 -0.38 -0.38 2.75 1.15
Profitability Margins
Gross Profit Margin
66.72%27.59%27.59%64.35%63.37%
EBIT Margin
11.41%4.68%4.68%4.63%14.29%
EBITDA Margin
16.66%9.60%9.60%9.10%18.29%
Operating Profit Margin
23.58%5.34%5.34%13.10%15.11%
Pretax Profit Margin
7.76%0.31%0.31%6.82%11.84%
Net Profit Margin
5.66%-12.71%-12.71%2.34%7.74%
Continuous Operations Profit Margin
5.66%-15.50%-15.50%-0.70%8.16%
Net Income Per EBT
73.00%-4114.72%-4114.72%34.23%65.34%
EBT Per EBIT
32.88%5.78%5.78%52.09%78.33%
Return on Assets (ROA)
0.00%-10.46%-10.46%1.53%5.51%
Return on Equity (ROE)
8.72%-19.13%-19.13%3.14%10.36%
Return on Capital Employed (ROCE)
0.00%7.39%7.39%11.64%14.85%
Return on Invested Capital (ROIC)
0.00%-329.12%-329.12%4.86%9.34%
Return on Tangible Assets
0.00%-11.53%-11.53%1.75%6.36%
Earnings Yield
1.36%-5.42%-5.42%2.27%7.55%
Efficiency Ratios
Receivables Turnover
0.00 6.36 6.36 3.10 3.93
Payables Turnover
0.00 3.37 3.37 1.90 1.95
Inventory Turnover
0.00 3.40 3.40 1.52 1.78
Fixed Asset Turnover
0.00 3.34 3.34 2.54 2.62
Asset Turnover
0.00 0.82 0.82 0.66 0.71
Working Capital Turnover Ratio
8.00 3.27 3.67 3.02 3.61
Cash Conversion Cycle
0.00 56.44 56.44 164.70 110.26
Days of Sales Outstanding
0.00 57.42 57.42 117.56 92.98
Days of Inventory Outstanding
0.00 107.23 107.23 239.56 204.60
Days of Payables Outstanding
0.00 108.21 108.21 192.43 187.31
Operating Cycle
0.00 164.66 164.66 357.12 297.57
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -9.41 -9.41 22.16 39.29
Free Cash Flow Per Share
0.00 -41.25 -41.25 0.62 11.29
CapEx Per Share
0.00 31.84 31.84 21.54 28.00
Free Cash Flow to Operating Cash Flow
0.00 4.38 4.38 0.03 0.29
Dividend Paid and CapEx Coverage Ratio
0.00 -0.26 -0.26 0.84 1.26
Capital Expenditure Coverage Ratio
0.00 -0.30 -0.30 1.03 1.40
Operating Cash Flow Coverage Ratio
0.00 -0.22 -0.22 0.14 0.28
Operating Cash Flow to Sales Ratio
0.00 -0.02 -0.02 0.05 0.09
Free Cash Flow Yield
0.00%-4.20%-4.20%0.13%2.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
73.73 -18.46 -18.46 44.11 13.24
Price-to-Sales (P/S) Ratio
4.17 2.35 2.35 1.03 1.02
Price-to-Book (P/B) Ratio
6.28 3.53 3.53 1.38 1.37
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -23.82 -23.82 743.79 39.15
Price-to-Operating Cash Flow Ratio
0.00 -104.43 -104.43 20.97 11.25
Price-to-Earnings Growth (PEG) Ratio
-2.63 0.03 0.03 -0.64 -4.51
Price-to-Fair Value
6.28 3.53 3.53 1.38 1.37
Enterprise Value Multiple
25.04 24.06 24.06 14.07 6.75
Enterprise Value
555.40B 272.94B 272.94B 162.97B 150.23B
EV to EBITDA
25.04 24.06 24.06 14.07 6.75
EV to Sales
4.17 2.31 2.31 1.28 1.23
EV to Free Cash Flow
0.00 -23.45 -23.45 924.42 47.16
EV to Operating Cash Flow
0.00 -102.82 -102.82 26.06 13.55
Tangible Book Value Per Share
313.40 230.82 230.82 262.43 253.49
Shareholders’ Equity Per Share
313.40 278.14 278.14 335.75 322.03
Tax and Other Ratios
Effective Tax Rate
0.27 51.17 51.17 0.57 0.31
Revenue Per Share
471.49 418.66 418.66 450.99 431.45
Net Income Per Share
26.69 -53.22 -53.22 10.53 33.37
Tax Burden
0.73 -41.15 -41.15 0.34 0.65
Interest Burden
0.68 0.07 0.07 1.47 0.83
Research & Development to Revenue
0.07 0.10 0.10 0.10 0.11
SG&A to Revenue
0.06 0.02 0.02 0.02 0.03
Stock-Based Compensation to Revenue
>-0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.00 0.18 0.18 0.72 0.77
Currency in INR